Recipharm in Uppsala

The Recipharm Uppsala facility is a key site in Recipharm’s European CDMO network. Located in Uppsala, Sweden, the site specialises in API production and the manufacture of oral solid and suppository dosage forms. The facility supports customers worldwide with high-quality, compliant manufacturing, fully integrated into Recipharm’s global services.

Site capabilities

The Uppsala facility offers flexible and scalable production, ensuring safe and compliant manufacturing throughout the product lifecycle.

Core manufacturing expertise

• Active Pharmaceutical Ingredients (API) production
• Coated and uncoated tablets
• Suppositories

Integrated operations

• Packaging and bulk product handling
• Bottling and serialisation
• Manual aggregation processes
• EU release of finished products

Related services

The Uppsala site works closely with Recipharm’s global CDMO capabilities to support the full product lifecycle:

• Oral solid dose services
• Packaging and serialization services
• Semi-solid production
• Regulatory

Quality, Compliance, and Regulatory Readiness

Global regulatory approvals

The Uppsala site is inspected and approved by major regulatory authorities:

• Swedish MPA (EU GMP)
• U.S. FDA
• PMDA (Japan)

Certified Management Systems

• ISO 14001 – Environmental Management
• ISO 45001 – Occupational Health & Safety Management

Sustainability commitment

EcoVadis Bronze rating, reflecting Recipharm’s strong ESG and sustainability performance

Careers at Uppsala

Recipharm Uppsala is part of a global network of manufacturing facilities delivering high-quality pharmaceutical products.

Explore the latest careers